相关实验视频
Updated: Feb 28, 2026

09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
30.3K
从乳腺管道增生至乳腺癌的复杂途径:非典型形式的恶性瘤风险增加
Bogdan-Alexandru Gheban1,2, Lavinia Patricia Mocan3, Adina Bianca Boșca3
1Discipline of Fundamental Sciences, Faculty of Medical Assistance and Health Sciences, Iuliu Hațieganu University of Medicine and Pharmacy, Emil Isaac nr. 8, 400023 Cluj-Napoca, Romania.
Biomedicines
|February 27, 2026
概括
乳腺管道过度增生与缺血症携带更高的乳腺癌风险. 了解推动进展的分子和环境因素是有针对性的监测和预防策略的关键.
科学领域:
- 乳腺病理学 乳腺病理学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 乳腺管道增生包括良性乳腺病变,具有不同的恶性转变风险.
- 过度增生症中的无型性与进化到 in situ 导管癌和侵袭性乳腺癌的可能性增加相关.
研究的目的:
- 审查导致乳腺管道增生不同进展潜力的因素.
- 综合了解流行病学,组织病理学,分子和环境对增生症进展的影响.
主要方法:
- 来自PubMed.Med等数据库的关键研究的文献评论.
- 专注于分类,风险分层,遗传/表观遗传机制,瘤微环境和可修改因素.
主要成果:
- 良性乳腺病变被分为非增殖性,增殖性无异型,以及具有异型的增殖性 (例如,异型管道性增殖).
- 型症意味着在基因变化,表观遗传变化和瘤微环境动态的影响下,局部向低级管道癌的进展.
- 饮食因素 (高脂肪饮食,肥胖) 和环境毒素 (内分泌干扰剂,农药,辐射) 通过炎症,胰岛素耐药性,基因组不稳定性和其他机制加剧进展.
结论:
- 对于高风险的增血症,需要分层监测和基于生物标志物的干预措施.
- 改变生活方式和了解分子形状对于个性化预防策略至关重要.
更多相关视频
相关概念视频
Tumor Progression
7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
The Mammary Glands
2.5K
The female breast is a hemispheric projection of variable size positioned anterior to the pectoralis major and serratus anterior muscles. A fascia layer composed of dense, irregular connective tissue connects it to these muscles.
Each breast features a pigmented projection known as the nipple, through which milk emerges via closely spaced openings of ducts, referred to as lactiferous ducts. Surrounding the nipple is a circular pigmented area of skin named the areola, which appears rough due to...
Each breast features a pigmented projection known as the nipple, through which milk emerges via closely spaced openings of ducts, referred to as lactiferous ducts. Surrounding the nipple is a circular pigmented area of skin named the areola, which appears rough due to...
2.5K
Cancers Originate from Somatic Mutations in a Single Cell
15.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.1K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K

